Banque de Luxembourg Investments (BLI)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,600
Closed -$369K 178
2025
Q2
$369K Hold
13,600
0.01% 174
2025
Q1
$422K Sell
13,600
-1,400
-9% -$49.7K 0.01% 136
2024
Q4
$591K Buy
+15,000
New +$717K 0.02% 131

Other funds holding MRNA

Banque de Luxembourg Investments (BLI)'s MRNA Position: Q3 2025 in Review

Banque de Luxembourg Investments (BLI) sold out of Moderna (MRNA) in Q3 2025, closing a stake of 13,600 shares — an estimated $369K sold.

Banque de Luxembourg Investments (BLI) first reported a position in MRNA in Q4 2024 and held it in 3 quarters. The position peaked at $591K in Q4 2024. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Banque de Luxembourg Investments (BLI) reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Banque de Luxembourg Investments (BLI) sold 13,600 Moderna shares in Q3 2025, an estimated $369K.
  • Banque de Luxembourg Investments (BLI) first reported a position in Moderna in Q4 2024 and held it in 3 quarters.
  • Banque de Luxembourg Investments (BLI)'s Moderna position peaked at $591K in Q4 2024.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q3 2025, filed 10 Nov 2025.